ASHER BORRADAILE: Open Payments
NPI 1396413357 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 88 payments from 15 companies in 2025. Trend: 2023 $1,065 · 2024 $719 · 2025 $1,885
Food & beverage: $1,808Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $439 |
| Janssen Biotech, Inc. | 14 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $283 |
| Ardelyx, Inc. | 7 | $181 |
| Madrigal Pharmaceuticals | 6 | $125 |
| GENZYME CORPORATION | 1 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| Biocon Biologics Inc | 2 | $51 |
| Intercept Pharmaceuticals, Inc. | 2 | $49 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, IBSRELA, SKYRIZI, REZDIFFRA, LINZESS, XIFAXAN.
Industry payments across FL — which companies pay providers there.
